Search

Home > The Bio Report > A Test for Data-Driven Drug Development
Podcast: The Bio Report
Episode:

A Test for Data-Driven Drug Development
Category: Business
Duration: 00:41:49
Publish Date: 2021-06-10 08:00:23
Description: Sumitomo Dainippon Pharma’s $3 billion acquisition of Roivant Sciences, which gave rise to Sumitovant, represents an effort by the Japanese drug company to make the drug development process faster and more efficient. A critical piece of this effort is steps the company has taken to harness information technology to capitalize on existing knowledge to inform decision making. We spoke to Bill McMahon, chief algorithmic analytics officer of Sumitovant, about the approach Sumitovant is taking, the way uses information technology to improve the drug development process, and how the subsidiary may be influencing the way its parent company operates.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes
The Bio Repo ..